Archives of Oral Biology
Volume 54, Issue 11 , Pages 1046-1051 , November 2009

Effect of nonsurgical periodontal therapy on crevicular fluid levels of Cathepsin K in periodontitis

,Accepted 26 August 2009.

References 

  1. Giannobile WV. Host-response therapeutics for periodontal diseases. J Periodontol. 2008;79:1592–1600
  2. Dickinson DP. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med. 2002;13(3):238–275
  3. Zavasjnik-Bergant T, Turk B. Cysteine cathepsins in the immune response. Tissue Antigens. 2006;67:349–355
  4. Goto T, Yamaza T, Tanaka T. Cathepsins in the osteoclast. J Electron Microsc. 2003;52(6):551–558
  5. Ahlberg J, Berkenstam A, Henell F, Glaumann H. Degradation of short and long lived proteins in isolated rat liver lysosomes. Effects of pH, temperature, and proteolytic inhibitors. J Biol Chem. 1985;260:5847–5854
  6. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, et al. Cathepsin K but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996;271:12511–12516
  7. Meier C, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, et al. concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Clin Lab. 2006;52:1–10
  8. Montonen M, Li TF, Lukinmaa PL, Sakai E, Hukkanen M, Sukura A, et al. RANKL and Cathepsin K in diffuse sclerosing osteomyelitis of the mandible. J Oral Pathol Med. 2006;35:620–625
  9. Hummel KM, Petrow PK, Franz JK, Muller-Ladner U, Aicher WK, Gay RE, et al. Cysteine proteinase Cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol. 1998;25:1887–1894
  10. Skoumal M, Haberhauer G, Kolarz G, Hawa G, Woloszczuk W, Klingler A. Serum Cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction. Arthritis Res Ther. 2005;7:R65–R70
  11. Wendling D, Cedoz J-P, Racadot E. Serum levels of MMP-3 and Cathepsin K in patients with ankylosing spondylitis: effect of TNFα antagonist therapy. Joint Bone Spine. 2008;75:559–562
  12. Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, et al. Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006;113:98–107
  13. Hie M, Shimono M, Fujii K, Tsukamoto I. Increased Cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone. 2007;41:1045–1050
  14. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 2004;5:443–453
  15. Rocken C, Fandrich M, Stix B, Tannert A, Hortschansky P, Reinheckel T, et al. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. J Pathol. 2006;210:478–487
  16. Yin X, Han J, Luo T, Wang L, Chen S, Zhao Y, et al. Adipocyte differentiation and its potential role in the pathogenesis of obesity. J Clin Endocrinol Metab. 2006;91:4520–4527
  17. Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Bromme D, et al. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int. 2003;73:380–386
  18. Ohba Y, Ohba T, Terai K, Moriyama K. Expression of Cathepsin K mRNA during experimental tooth movement in rat as revealed by in situ hybridization. Arch Oral Biol. 2000;45:63–69
  19. Strbac GD, Monov G, Cei S, Kandler B, Watzek G, Gruber R, et al. levels in the crevicular fluid of dental implants: a pilot study. J Clin Periodontol. 2006;33:302–308
  20. Mogi M, Otogoto J. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis. Arch Oral Biol. 2007;52:894–898
  21. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533
  22. Griffiths GS. Formation, collection and significance of gingival crevicular fluid. Periodontol 2000. 2003;31:32–42
  23. Pentikainen MO, Oorni K, Ala-Korpela M, Kovanen PT. Modified LDL trigger of atherosclerosis and inflammation in the arterial intima. J Int Med. 2000;247:359–370
  24. Runger TM, Quintanilla-Dieck MJ, Bhawan J. Role of Cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol. 2007;127:293–297
  25. Yasuda Y, Kaleta J, Bromme DT. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev. 2005;57:973–993
  26. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP. Human Cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J. 1998;331:727–732
  27. Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with Cathepsin K. Bone. 2000;26:367–373
  28. Stroup GB, Lark MW, Veber DF, Bhattacharyya A, Blake S, Dare LC, et al. Potent and selective inhibition of human Cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res. 2001;16:1739–1746

PII: S0003-9969(09)00226-X

doi: 10.1016/j.archoralbio.2009.08.007

Archives of Oral Biology
Volume 54, Issue 11 , Pages 1046-1051 , November 2009

Article Tools